SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-041854
Filing Date
2015-02-10
Accepted
2015-02-10 17:31:01
Documents
8
Period of Report
2015-02-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d869735d8k.htm 8-K 21330
2 EX-4.1 d869735dex41.htm EX-4.1 63661
3 EX-4.2 d869735dex42.htm EX-4.2 63379
4 EX-4.3 d869735dex43.htm EX-4.3 55138
5 EX-4.4 d869735dex44.htm EX-4.4 55294
6 EX-4.5 d869735dex45.htm EX-4.5 56894
7 EX-4.6 d869735dex46.htm EX-4.6 56573
8 EX-5.1 d869735dex51.htm EX-5.1 7119
  Complete submission text file 0001193125-15-041854.txt   380641
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 15595201
SIC: 2834 Pharmaceutical Preparations